DFS vs ERNA
DFS (DFS) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
DFS (DFS) common stock.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
DFS does not have a complete income-statement cache yet.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the DFS and ERNA stock pages for the full models.
Not investment advice.